The effect of dopamine replacement therapy on behaviour in people with Parkinson’s disease
Publisher:
Parkinson's Disease SocietyDate published:
7 April, 2006Region:
United Kingdom Publication type:
researchIn Parkinson’s, there is a loss of nerve cells (neurons), in the part of the brain known as the substantia nigra which is, therefore, unable to function normally. These cells produce a chemical known as dopamine, which transmits messages to other parts of the brain that co-ordinate movement. Therefore, a deficiency of dopamine is seen in people with Parkinson’s.
Similar entries
- Developing a source of neurons to replace the nerve cells lost in Parkinson’s
- Involvement of glial cells in the development and progression of Parkinson’s disease
- Modulation of metabotropic glutamate receptors as a novel neuroprotective strategy in Parkinson’s disease: A preliminary investi
- Parkinson's linked to vitamin D
- Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
- Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years
- New funding at Oxford for research into the potential benefits of nicotine
- New funding at University of Oxford for research into faulty brain signalling in Parkinson's
- Parkinson's stem cell breakthrough
- Parkinson’s News





